Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease.

Motegi SI, Sekiguchi A, Toki S, Kishi C, Endo Y, Yasuda M, Ikeuchi H, Sakairi T, Hara K, Yamaguchi K, Maeno T, Hiromura K, Ishikawa O.

Eur J Dermatol. 2019 Oct 16. doi: 10.1684/ejd.2019.3634. [Epub ahead of print]

PMID:
31617496
2.

Urinary Activin A is a novel biomarker reflecting renal inflammation and tubular damage in ANCA-associated vasculitis.

Takei Y, Takahashi S, Nakasatomi M, Sakairi T, Ikeuchi H, Kaneko Y, Hiromura K, Nojima Y, Maeshima A.

PLoS One. 2019 Oct 15;14(10):e0223703. doi: 10.1371/journal.pone.0223703. eCollection 2019.

3.

Attenuation of renal fibrosis after unilateral ureteral obstruction in mice lacking the N-type calcium channel.

Mishima K, Nakasatomi M, Takahashi S, Ikeuchi H, Sakairi T, Kaneko Y, Hiromura K, Nojima Y, Maeshima A.

PLoS One. 2019 Oct 9;14(10):e0223496. doi: 10.1371/journal.pone.0223496. eCollection 2019.

4.

Clinical features of patients with anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis complicated by spontaneous pneumomediastinum.

Yamaguchi K, Yamaguchi A, Itai M, Kashiwagi C, Takehara K, Aoki S, Sawada Y, Taguchi K, Umetsu K, Oshima K, Uchida M, Takemura M, Hara K, Motegi SI, Muro Y, Nakasatomi M, Sakairi T, Hiromura K, Kurabayashi M, Maeno T.

Clin Rheumatol. 2019 Dec;38(12):3443-3450. doi: 10.1007/s10067-019-04729-5. Epub 2019 Aug 16.

PMID:
31420814
5.

A relapsing case of pulmonary-renal syndrome after a sequential rise in MPO-ANCA and anti-GBM antibodies.

Hoshino A, Sakairi T, Kayakabe K, Baba M, Ando M, Kimura H, Motohashi R, Nojima Y, Hiromura K.

CEN Case Rep. 2019 Aug;8(3):221-225. doi: 10.1007/s13730-019-00397-1. Epub 2019 Apr 3.

6.

Enhancement of HGF-induced tubulogenesis by endothelial cell-derived GDNF.

Nakasatomi M, Takahashi S, Sakairi T, Ikeuchi H, Kaneko Y, Hiromura K, Nojima Y, Maeshima A.

PLoS One. 2019 Mar 7;14(3):e0212991. doi: 10.1371/journal.pone.0212991. eCollection 2019.

7.

Hypertrophic pachymeningitis associated with antineutrophil cytoplasmic antibody-associated vasculitis: a case series of 15 patients.

Sakairi T, Sakurai N, Nakasatomi M, Ikeuchi H, Kaneko Y, Maeshima A, Nojima Y, Hiromura K.

Scand J Rheumatol. 2019 May;48(3):218-224. doi: 10.1080/03009742.2018.1498916. Epub 2018 Nov 5.

PMID:
30394816
8.

Hepatitis E during Tocilizumab Therapy in a Patient with Rheumatoid Arthritis: Case Report and Literature Review.

Ikeuchi H, Koinuma K, Nakasatomi M, Sakairi T, Kaneko Y, Maeshima A, Yamazaki Y, Okamoto H, Mimura T, Mochida S, Nojima Y, Hiromura K.

Case Rep Rheumatol. 2018 Jul 26;2018:6873276. doi: 10.1155/2018/6873276. eCollection 2018.

9.

Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.

Yamaguchi K, Yamaguchi A, Kashiwagi C, Sawada Y, Taguchi K, Umetsu K, Oshima K, Uchida M, Suzuki M, Kono S, Takemura M, Masubuchi H, Kitahara S, Hara K, Maeno T, Motegi SI, Muro Y, Sakairi T, Hisada T, Kurabayashi M.

Respir Med. 2018 Jul;140:1-5. doi: 10.1016/j.rmed.2018.05.010. Epub 2018 May 22.

PMID:
29957268
10.

The Analysis of Renal Infiltrating Cells in Acute Tubulointerstitial Nephritis Induced by Anti-PD-1 Antibodies: A Case Report and Review of the Literature.

Tabei A, Watanabe M, Ikeuchi H, Nakasatomi M, Sakairi T, Kaneko Y, Maeshima A, Kaira K, Hirato J, Nojima Y, Hiromura K.

Intern Med. 2018 Nov 1;57(21):3135-3139. doi: 10.2169/internalmedicine.0444-17. Epub 2018 Jun 6. Review.

11.

TGF-β1 alters DNA methylation levels in promoter and enhancer regions of the WT1 gene in human podocytes.

Hamatani H, Sakairi T, Ikeuchi H, Kaneko Y, Maeshima A, Nojima Y, Hiromura K.

Nephrology (Carlton). 2019 May;24(5):575-584. doi: 10.1111/nep.13411.

PMID:
29851165
12.

Discovery of evocalcet, a next-generation calcium-sensing receptor agonist for the treatment of hyperparathyroidism.

Miyazaki H, Ikeda Y, Sakurai O, Miyake T, Tsubota R, Okabe J, Kuroda M, Hisada Y, Yanagida T, Yoneda H, Tsukumo Y, Tokunaga S, Kawata T, Ohashi R, Fukuda H, Kojima K, Kannami A, Kifuji T, Sato N, Idei A, Iguchi T, Sakairi T, Moritani Y.

Bioorg Med Chem Lett. 2018 Jun 15;28(11):2055-2060. doi: 10.1016/j.bmcl.2018.04.055. Epub 2018 Apr 24.

13.

Identification of Urinary Activin A as a Novel Biomarker Reflecting the Severity of Acute Kidney Injury.

Takahashi S, Nakasatomi M, Takei Y, Ikeuchi H, Sakairi T, Kaneko Y, Hiromura K, Nojima Y, Maeshima A.

Sci Rep. 2018 Mar 26;8(1):5176. doi: 10.1038/s41598-018-23564-3.

14.

The correlation of urinary podocytes and podocalyxin with histological features of lupus nephritis.

Ikuma D, Hiromura K, Kajiyama H, Suwa J, Ikeuchi H, Sakairi T, Kaneko Y, Maeshima A, Kurosawa H, Hirayama Y, Yokota K, Araki Y, Sato K, Asanuma YF, Akiyama Y, Hara M, Nojima Y, Mimura T.

Lupus. 2018 Mar;27(3):484-493. doi: 10.1177/0961203317734918. Epub 2017 Oct 19.

PMID:
29050536
15.

Involvement of infiltrating macrophage-derived activin A in the progression of renal damage in MRL-lpr mice.

Kadiombo AT, Maeshima A, Kayakabe K, Ikeuchi H, Sakairi T, Kaneko Y, Hiromura K, Nojima Y.

Am J Physiol Renal Physiol. 2017 Feb 1;312(2):F297-F304. doi: 10.1152/ajprenal.00191.2016. Epub 2016 Nov 23.

16.

Renal outcomes in mixed proliferative and membranous lupus nephritis (Class III/IV + V): A long-term observational study.

Ikeuchi H, Hiromura K, Kayakabe K, Tshilela KA, Uchiyama K, Hamatani H, Sakairi T, Kaneko Y, Maeshima A, Nojima Y.

Mod Rheumatol. 2016 Nov;26(6):908-913. doi: 10.3109/14397595.2016.1158896. Epub 2016 Apr 26.

PMID:
27115200
17.

Constraints on Earth's inner core composition inferred from measurements of the sound velocity of hcp-iron in extreme conditions.

Sakamaki T, Ohtani E, Fukui H, Kamada S, Takahashi S, Sakairi T, Takahata A, Sakai T, Tsutsui S, Ishikawa D, Shiraishi R, Seto Y, Tsuchiya T, Baron AQ.

Sci Adv. 2016 Feb 26;2(2):e1500802. doi: 10.1126/sciadv.1500802. eCollection 2016 Feb.

18.

Histological findings in the spleen affected by adult-onset Still's disease: a report of three cases.

Sakairi T, Hiromura K, Kaneko Y, Maeshima A, Hirato J, Nojima Y.

Clin Exp Rheumatol. 2016 May-Jun;34(3):566-7. Epub 2016 Feb 2. No abstract available.

PMID:
26841850
19.

Successful treatment of severe crescentic lupus nephritis by multi-target therapy using tacrolimus and mycophenolate mofetil.

Mochizuki K, Kayakabe K, Hiromura K, Ando M, Sakurai N, Ikeuchi H, Sakairi T, Kaneko Y, Maeshima A, Nojima Y.

CEN Case Rep. 2015 Nov;4(2):126-130. doi: 10.1007/s13730-014-0151-0. Epub 2014 Oct 12.

20.

Novel approach for the detection of tubular cell migration into the interstitium during renal fibrosis in rats.

Nakasatomi M, Maeshima A, Mishima K, Ikeuchi H, Sakairi T, Kaneko Y, Hiromura K, Nojima Y.

Fibrogenesis Tissue Repair. 2015 Jul 10;8:12. doi: 10.1186/s13069-015-0030-0. eCollection 2015.

21.

Glomerular cytokine expression in murine lupus nephritis.

Tshilela KA, Ikeuchi H, Matsumoto T, Kuroiwa T, Sakurai N, Sakairi T, Kaneko Y, Maeshima A, Hiromura K, Nojima Y.

Clin Exp Nephrol. 2016 Feb;20(1):23-9. doi: 10.1007/s10157-015-1123-1. Epub 2015 May 19.

PMID:
25985839
22.

Gene expression profiling in the lungs of phenylhydrazine-treated rats: the contribution of pro-inflammatory response and endothelial dysfunction to acute thrombosis.

Sato H, Terasaki N, Sakairi T, Tanaka M, Takahashi K.

Exp Toxicol Pathol. 2015 Feb;67(2):205-10. doi: 10.1016/j.etp.2014.11.011. Epub 2015 Jan 8.

PMID:
25579645
23.

Two cases of ulcerative colitis developing in rheumatoid arthritis patients during abatacept therapy.

Motohashi R, Ikeuchi H, Hiromura K, Ohishi Y, Sakurai N, Sakairi T, Kaneko Y, Maeshima A, Nojima Y.

Scand J Gastroenterol. 2014 Oct;49(10):1270-1. doi: 10.3109/00365521.2014.946087. Epub 2014 Aug 13. No abstract available.

PMID:
25115461
24.

Expression of a novel stress-inducible protein, sestrin 2, in rat glomerular parietal epithelial cells.

Hamatani H, Hiromura K, Sakairi T, Takahashi S, Watanabe M, Maeshima A, Ohse T, Pippin JW, Shankland SJ, Nojima Y.

Am J Physiol Renal Physiol. 2014 Sep 15;307(6):F708-17. doi: 10.1152/ajprenal.00625.2013. Epub 2014 Jul 23.

25.

Follistatin, an activin antagonist, ameliorates renal interstitial fibrosis in a rat model of unilateral ureteral obstruction.

Maeshima A, Mishima K, Yamashita S, Nakasatomi M, Miya M, Sakurai N, Sakairi T, Ikeuchi H, Hiromura K, Hasegawa Y, Kojima I, Nojima Y.

Biomed Res Int. 2014;2014:376191. doi: 10.1155/2014/376191. Epub 2014 May 5.

26.

A case of ANCA-negative renal small-vessel vasculitis with tubulointerstitial infiltration of IgG4-positive plasma cells.

Sakairi T, Okabe S, Hiromura K, Motegi S, Sakurai N, Ikeuchi H, Kaneko Y, Maeshima A, Hirato J, Nojima Y.

Mod Rheumatol. 2016 Sep;26(5):780-3. doi: 10.3109/14397595.2014.915510. Epub 2014 May 20.

PMID:
24842479
27.

Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis.

Ikeuchi H, Hiromura K, Takahashi S, Mishima K, Sakurai N, Sakairi T, Kaneko Y, Maeshima A, Kuroiwa T, Nojima Y.

Mod Rheumatol. 2014 Jul;24(4):618-25. doi: 10.3109/14397595.2013.844397. Epub 2013 Oct 21.

PMID:
24252014
28.

TGF-β1 stimulates mitochondrial oxidative phosphorylation and generation of reactive oxygen species in cultured mouse podocytes, mediated in part by the mTOR pathway.

Abe Y, Sakairi T, Beeson C, Kopp JB.

Am J Physiol Renal Physiol. 2013 Nov 15;305(10):F1477-90. doi: 10.1152/ajprenal.00182.2013. Epub 2013 Sep 18.

29.

SIRPα signaling regulates podocyte structure and function.

Takahashi S, Tomioka M, Hiromura K, Sakairi T, Hamatani H, Watanabe M, Ikeuchi H, Kaneko Y, Maeshima A, Aoki T, Ohnishi H, Matozaki T, Nojima Y.

Am J Physiol Renal Physiol. 2013 Sep 15;305(6):F861-70. doi: 10.1152/ajprenal.00597.2012. Epub 2013 Jul 10.

30.

Nephrotic syndrome caused by immune-mediated acquired LCAT deficiency.

Takahashi S, Hiromura K, Tsukida M, Ohishi Y, Hamatani H, Sakurai N, Sakairi T, Ikeuchi H, Kaneko Y, Maeshima A, Kuroiwa T, Yokoo H, Aoki T, Nagata M, Nojima Y.

J Am Soc Nephrol. 2013 Jul;24(8):1305-12. doi: 10.1681/ASN.2012090913. Epub 2013 Apr 25.

31.

[Case report: posterior reversible encephalopathy syndrome and scleroderma renal crisis developed in a patient with overlap syndrome after treatment with high-dose steroids and tacrolimus].

Matsui A, Ikeuchi H, Shimizu A, Takahashi S, Mishima K, Sakurai N, Sakairi T, Kaneko Y, Maeshima A, Hiromura K, Nojima Y.

Nihon Naika Gakkai Zasshi. 2012 Jul 10;101(7):2051-4. Japanese. No abstract available.

PMID:
22897011
32.

Interleukin-1β measurement in stimulated whole blood cultures is useful to predict response to anti-TNF therapies in rheumatoid arthritis.

Kayakabe K, Kuroiwa T, Sakurai N, Ikeuchi H, Kadiombo AT, Sakairi T, Kaneko Y, Maeshima A, Hiromura K, Nojima Y.

Rheumatology (Oxford). 2012 Sep;51(9):1639-43. doi: 10.1093/rheumatology/kes094. Epub 2012 May 16.

PMID:
22596214
33.

Interleukin-6 promotes destabilized angiogenesis by modulating angiopoietin expression in rheumatoid arthritis.

Kayakabe K, Kuroiwa T, Sakurai N, Ikeuchi H, Kadiombo AT, Sakairi T, Matsumoto T, Maeshima A, Hiromura K, Nojima Y.

Rheumatology (Oxford). 2012 Sep;51(9):1571-9. doi: 10.1093/rheumatology/kes093. Epub 2012 May 16.

PMID:
22596210
34.

Hematological and morphological investigation of thrombogenic mechanisms in the lungs of phenylhydrazine-treated rats.

Sato H, Sakairi T, Fujimura H, Sugimoto J, Kume E, Kitamura K, Takahashi K.

Exp Toxicol Pathol. 2013 May;65(4):457-62. doi: 10.1016/j.etp.2012.01.004. Epub 2012 Mar 7.

PMID:
22402172
35.

Gene expression in livers of BALB/C and C57BL/6J mice fed a high-fat diet.

Nishikawa S, Sugimoto J, Okada M, Sakairi T, Takagi S.

Toxicol Pathol. 2012;40(1):71-82. doi: 10.1177/0192623311422078. Epub 2011 Nov 21.

PMID:
22105644
36.

Hydronephrosis caused by a relapse of granulomatosis with polyangiitis (Wegener's).

Umemoto A, Ikeuchi H, Hiromura K, Hamatani H, Sakurai N, Sakairi T, Matsumoto T, Maeshima A, Kuroiwa T, Nojima Y.

Mod Rheumatol. 2012 Aug;22(4):616-20. doi: 10.1007/s10165-011-0554-0. Epub 2011 Nov 9.

PMID:
22065104
37.

Spontaneous amphophilic focus in the liver of a young Sprague-Dawley rat.

Sato H, Sakairi T, Takagi S, Kitamura K.

Exp Toxicol Pathol. 2013 Jan;65(1-2):35-7. doi: 10.1016/j.etp.2011.05.006. Epub 2011 Jun 12.

PMID:
21665447
38.

TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes.

Sakairi T, Abe Y, Kopp JB.

Nephrol Dial Transplant. 2011 Sep;26(9):2746-52. doi: 10.1093/ndt/gfr061. Epub 2011 Mar 4.

39.

Effects of proteasome inhibitors on rat renal fibrosis in vitro and in vivo.

Sakairi T, Hiromura K, Takahashi S, Hamatani H, Takeuchi S, Tomioka M, Maeshima A, Kuroiwa T, Nojima Y.

Nephrology (Carlton). 2011 Jan;16(1):76-86. doi: 10.1111/j.1440-1797.2010.01367.x.

PMID:
21175982
40.

Diet modification and its influence on metabolic and related pathological alterations in the SHR/NDmcr-cp rat, an animal model of the metabolic syndrome.

Kawai K, Sakairi T, Harada S, Shinozuka J, Ide M, Sato H, Tanaka M, Toriumi W, Kume E.

Exp Toxicol Pathol. 2012 May;64(4):333-8. doi: 10.1016/j.etp.2010.09.006. Epub 2010 Oct 20.

PMID:
20965707
41.

Cell-cell contact regulates gene expression in CDK4-transformed mouse podocytes.

Sakairi T, Abe Y, Jat PS, Kopp JB.

Am J Physiol Renal Physiol. 2010 Oct;299(4):F802-9. doi: 10.1152/ajprenal.00205.2010. Epub 2010 Jul 28.

42.

Nestin is a novel marker for renal tubulointerstitial injury in immunoglobulin A nephropathy.

Tomioka M, Hiromura K, Sakairi T, Takeuchi S, Maeshima A, Kaneko Y, Kuroiwa T, Takeuchi T, Nojima Y.

Nephrology (Carlton). 2010 Aug;15(5):568-74. doi: 10.1111/j.1440-1797.2010.01342.x.

PMID:
20649878
43.

Proteomic analysis identifies insulin-like growth factor-binding protein-related protein-1 as a podocyte product.

Matsumoto T, Hess S, Kajiyama H, Sakairi T, Saleem MA, Mathieson PW, Nojima Y, Kopp JB.

Am J Physiol Renal Physiol. 2010 Oct;299(4):F776-84. doi: 10.1152/ajprenal.00597.2009. Epub 2010 Jul 14.

44.

The immunosuppressive drug mizoribine directly prevents podocyte injury in puromycin aminonucleoside nephrosis.

Takeuchi S, Hiromura K, Tomioka M, Takahashi S, Sakairi T, Maeshima A, Kaneko Y, Kuroiwa T, Nojima Y.

Nephron Exp Nephrol. 2010;116(1):e3-10. doi: 10.1159/000314668. Epub 2010 May 21.

PMID:
20502051
45.

Bioenergetic characterization of mouse podocytes.

Abe Y, Sakairi T, Kajiyama H, Shrivastav S, Beeson C, Kopp JB.

Am J Physiol Cell Physiol. 2010 Aug;299(2):C464-76. doi: 10.1152/ajpcell.00563.2009. Epub 2010 May 5.

46.

A Hepatocellular Adenoma in a Diet-induced Obese Mouse.

Kawai K, Sakairi T, Tanaka M, Shinozuka J, Ide M, Sato H, Fujiwara T, Sano F, Kume E.

J Toxicol Pathol. 2010 Mar;23(1):59-62. doi: 10.1293/tox.23.59. Epub 2010 Apr 5.

47.

Conditionally immortalized human podocyte cell lines established from urine.

Sakairi T, Abe Y, Kajiyama H, Bartlett LD, Howard LV, Jat PS, Kopp JB.

Am J Physiol Renal Physiol. 2010 Mar;298(3):F557-67. doi: 10.1152/ajprenal.00509.2009. Epub 2009 Dec 2.

48.
49.

Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats.

Ohta T, Masutomi N, Tsutsui N, Sakairi T, Mitchell M, Milburn MV, Ryals JA, Beebe KD, Guo L.

Toxicol Pathol. 2009 Jun;37(4):521-35. doi: 10.1177/0192623309336152.

PMID:
19458390
50.

Tetracycline-inducible gene expression in conditionally immortalized mouse podocytes.

Kajiyama H, Titus S, Austin CP, Chiotos K, Matsumoto T, Sakairi T, Kopp JB.

Am J Nephrol. 2009;29(3):153-63. doi: 10.1159/000151770. Epub 2008 Aug 28.

Supplemental Content

Loading ...
Support Center